BJCP 40th Anniversary: Moving Forward, Looking Back
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
FAULKNER J, McGibney D, Chasseaud L, Perry J, TAYLOR I
. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol. 1986; 22(1):21-5.
PMC: 1401071.
DOI: 10.1111/j.1365-2125.1986.tb02874.x.
View
2.
Andersson T, Miners J, Veronese M, Tassaneeyakul W, Meyer U, Birkett D
. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. Br J Clin Pharmacol. 1993; 36(6):521-30.
PMC: 1364656.
DOI: 10.1111/j.1365-2125.1993.tb00410.x.
View
3.
DesRoches C, Zinner D, Rao S, Iezzoni L, Campbell E
. Activities, productivity, and compensation of men and women in the life sciences. Acad Med. 2010; 85(4):631-9.
PMC: 7677863.
DOI: 10.1097/ACM.0b013e3181d2b095.
View
4.
Ged C, Rouillon J, Pichard L, Combalbert J, Bressot N, Bories P
. The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol. 1989; 28(4):373-87.
PMC: 1379986.
DOI: 10.1111/j.1365-2125.1989.tb03516.x.
View
5.
Sesardic D, Boobis A, Murray B, Murray S, Segura J, de la Torre R
. Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol. 1990; 29(6):651-63.
PMC: 1380167.
DOI: 10.1111/j.1365-2125.1990.tb03686.x.
View